Senolytics are drugs that are being developed to treat age-related diseases by targeting and eliminating senescent cells. These cells are thought to contribute to the decline in function that occurs with age, and senolytics could potentially help to slow down or even reverse this process. There is still much research to be done in this area, but senolytics show promise as a potential treatment for age-related diseases.
Some of the emerging trends in Senolytics include the use of small molecule drugs and biologics to target senescent cells, the development of novel delivery methods to target senescent cells, and the use of senolytics in combination with other therapeutic modalities such as immunotherapy.